免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

STA Satellite Max®

K号: K253658 · 2026-04-27

决定日期2026-04-27
产品代码JPA
咨询委员会HE 请注意,由于您只提供了“HE”作为输入,我无法提供完整的翻译。请提供完整的描述或文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

STA Satellite Max® is the device name listed in this FDA 510(k) record. The listed applicant is Diagnostica Stago, Inc.. It received FDA 510(k) clearance on 2026-04-27 under 510(k) number K253658. The device is classified under product code JPA. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the STA Satellite Max®?

STA Satellite Max® is a medical device that received FDA 510(k) clearance on 2026-04-27. The listed applicant is Diagnostica Stago, Inc.. The 510(k) number is K253658.

When did STA Satellite Max® receive FDA 510(k) clearance?

STA Satellite Max® received FDA 510(k) clearance on 2026-04-27, under 510(k) number K253658.

Who is the listed applicant for STA Satellite Max®?

FDA 510(k)记录将Diagnostica Stago, Inc.列为申请人。这本身并不能确立该设备的制造商。

What is the FDA product code for STA Satellite Max®?

The FDA product code for STA Satellite Max® is JPA.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Diagnostica Stago, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:JPA)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑